Medicine News and Research

RSS

Aspirin prescribed more often for stroke prevention in AF despite of dangerous side effects

Aspirin is still overprescribed for stroke prevention in atrial fibrillation (AF) despite the potential for dangerous side effects, according to research published today.

29 Jan 2014

CU receives cooperative agreement to develop technological system to determine effects chemical agents

The University of Colorado Boulder has been awarded a cooperative agreement worth up to $14.6 million from the Defense Advanced Research Projects Agency (DARPA) to develop a new technological system to rapidly determine how drugs and biological or chemical agents exert their effects on human cells.

29 Jan 2014

Researcher receives 2014 Japan Prize in Life Sciences for extraordinary work in the field of epigenetics

C. David Allis, a pioneer in the field of epigenetics whose discovery that chemical modifications of DNA-packaging proteins play a key role in regulating the activity of individual genes, will be awarded the 2014 Japan Prize in Life Sciences. The announcement, by the Japan Prize Foundation, was made at a press conference in Tokyo this morning.

29 Jan 2014

Study suggest that unique environmental stimulus may interact with genetic trait to initiate type 1 diabetes

Type 1 diabetes is a genetically-driven autoimmune disease of pancreatic beta-cells, whose origins remain unknown. Researchers at the Boston Medical Center (BMC) and Boston University School of Medicine (BUSM) discovered that skin cells from patients with type 1 diabetes display abnormal activity triggered by immune response mechanisms to environmental stimuli like a viral infection.

29 Jan 2014

Saudi Aramco, Johns Hopkins Medicine partner to strengthen health care services in Saudi Arabia

Saudi Aramco, a fully integrated global energy and chemicals enterprise, and Johns Hopkins Medicine, a leading U.S. academic health system with extensive experience in elevating care delivery worldwide, today inaugurated a first-of-its-kind health care joint venture in Dhahran, Saudi Arabia.

29 Jan 2014

UCSF awarded grant of $2.7M for collaborative project aimed at reducing premature births

UC San Francisco has been awarded a Bill & Melinda Gates Foundation grant of $2.7 million over three years for a collaborative project aimed at reducing premature births.

29 Jan 2014

Study: Genetic mutations in titin gene can cause skeletal muscle disease

A University of Arizona doctoral candidate has shown for the first time that genetic mutations in the titin gene can cause skeletal muscle myopathy, a disease in which muscle fibers do not function properly, resulting in muscle weakness.

29 Jan 2014

Scientists develop automated system that identifies high-risk osteoporosis patients

An automated system that identifies high-risk osteoporosis patients being treated for fractures and can generate letters encouraging follow-up is an effective way to promote osteoporosis intervention and prevent future fractures, according to Penn State College of Medicine researchers.

29 Jan 2014

Transgenic mouse model validates mutant IDH2 protein as candidate for targeted anticancer therapies

In recent years, mutations in two metabolic enzymes, isocitrate dehydrogenase-1 and 2 (IDH1 and IDH2), have been identified in approximately 20 percent of all acute myeloid leukemias (AML). As a result, mutant IDH proteins have been proposed as attractive drug targets for this common form of adult leukemia.

29 Jan 2014

Low levels of pro-inflammatory cytokine in brain are important for cognition

Although inflammation is frequently a cause of disease in the body, research from The University of Texas Health Science Center at San Antonio indicates that low levels of a pro-inflammatory cytokine in the brain are important for cognition. Cytokines are proteins produced by the immune system.

28 Jan 2014

New molecule reduces diabetic patients' higher risk of developing dementia, Alzheimer's

Researchers at the Hebrew university of Jerusalem have created a molecule that could potentially lower diabetic patients' higher risk of developing dementia or Alzheimer's disease.

28 Jan 2014

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has approved the Company's supplemental new drug application for three-times-a-week COPAXONE 40mg/mL, a new dose of COPAXONE.

28 Jan 2014

Anxiety, depression and meditation: an interview with Dr Madhav Goyal, Johns Hopkins University School of Medicine

We wanted to be broadly inclusive of any kind of meditation program, so we defined a meditation program to be any kind of structured meditation program that involved at a minimum 4 hours of training, with instructions to practice outside the classroom.

28 Jan 2014

Johns Hopkins researchers reveal how non-CpG methylation may contribute to Rett Syndrome

In normal development, all cells turn off genes they don’t need, often by attaching a chemical methyl group to the DNA, a process called methylation. Historically, scientists believed methyl groups could only stick to a particular DNA sequence: a cytosine followed by a guanine, called CpG. But in recent years, they have been found on other sequences, and so-called non-CpG methylation has been found in stem cells, and in neurons in the brain.

28 Jan 2014

New book looks at politics behind hospital provision in early twentieth-century

Professor Barry Doyle, lecturer in the School of Music, Humanities and Media at the University of Huddersfield, has published a new book looking at the politics behind hospital provision in the early twentieth-century.

28 Jan 2014

New approach for reversing hair loss uses stem cells to regenerate missing hair follicles

If the content of many a situation comedy, not to mention late-night TV advertisements, is to be believed, there's an epidemic of balding men, and an intense desire to fix their follicular deficiencies.

28 Jan 2014

Medac Pharma announces FDA acceptance of New Drug Application for MPI-2505

Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced the FDA acceptance of its New Drug Application (NDA) for its lead product candidate, MPI-2505, a subcutaneous injectable methotrexate (MTX) in a ready-to-use injection device, for which the proposed indications are rheumatoid arthritis (RA), poly-articular-course juvenile RA and psoriasis.

28 Jan 2014

Serious traumatic spinal cord injuries rising among older people in the U.S.

The number of serious traumatic spinal cord injuries is on the rise in the United States, and the leading cause no longer appears to be motor vehicle crashes, but falls, new Johns Hopkins research suggests.

28 Jan 2014

Researchers identify therapeutic target for cervix cancer

Gene related to the proliferation of cancerous cells blocked through molecular technology. A group of researchers from Mexico's General Hospital, Health Secretariat, Medicine Faculty and the Institute of Cellular Physiology of the National Autonomous University of Mexico (UNAM) identified a therapeutic target for cervix cancer: gene CDKN3.

28 Jan 2014

Number of serious traumatic spinal cord injuries is on the rise in US, shows study

28 Jan 2014

Medicine News and Research

Aspirin prescribed more often for stroke prevention in AF despite of dangerous side effects

CU receives cooperative agreement to develop technological system to determine effects chemical agents

Researcher receives 2014 Japan Prize in Life Sciences for extraordinary work in the field of epigenetics

Study suggest that unique environmental stimulus may interact with genetic trait to initiate type 1 diabetes

Saudi Aramco, Johns Hopkins Medicine partner to strengthen health care services in Saudi Arabia

UCSF awarded grant of $2.7M for collaborative project aimed at reducing premature births

Study: Genetic mutations in titin gene can cause skeletal muscle disease

Scientists develop automated system that identifies high-risk osteoporosis patients

Transgenic mouse model validates mutant IDH2 protein as candidate for targeted anticancer therapies

Low levels of pro-inflammatory cytokine in brain are important for cognition

New molecule reduces diabetic patients' higher risk of developing dementia, Alzheimer's

FDA approves Teva's sNDA for three-times-a-week COPAXONE 40mg/mL

Anxiety, depression and meditation: an interview with Dr Madhav Goyal, Johns Hopkins University School of Medicine

Johns Hopkins researchers reveal how non-CpG methylation may contribute to Rett Syndrome

New book looks at politics behind hospital provision in early twentieth-century

New approach for reversing hair loss uses stem cells to regenerate missing hair follicles

Medac Pharma announces FDA acceptance of New Drug Application for MPI-2505

Serious traumatic spinal cord injuries rising among older people in the U.S.

Researchers identify therapeutic target for cervix cancer

Number of serious traumatic spinal cord injuries is on the rise in US, shows study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News